Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ishmael A. Jaiyesimi"'
Autor:
Mandeep Singh Rahi, Vishal Jindal, Prachi Pednekar, Jay Parekh, Kulothungan Gunasekaran, Sorabh Sharma, Michael Stender, Ishmael A. Jaiyesimi
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
The advent of bone marrow transplant has opened doors to a different approach and offered a new treatment modality for various hematopoietic stem-cell-related disorders. Since the first bone marrow transplant in 1957, there has been significant progr
Externí odkaz:
https://doaj.org/article/f8c7acef53cb4cab9cb026a69feda6b8
Autor:
Navneet Singh, Ishmael A. Jaiyesimi, Nofisat Ismaila, Natasha B. Leighl, Hirva Mamdani, Tanyanika Phillips, Dwight H. Owen
Publikováno v:
Journal of Clinical Oncology. 41:e51-e62
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically r
Autor:
Ishmael A. Jaiyesimi, Dwight H. Owen, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Navneet Singh
Publikováno v:
Journal of Clinical Oncology. 41:e21-e30
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically r
Autor:
Dwight H. Owen, Navneet Singh, Nofisat Ismaila, Elizabeth Blanchard, Paul Celano, Narjust Florez, Dharamvir Jain, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Jarushka Naidoo, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Erin Schenk, Bryan J. Schneider, Lecia Sequist, David R. Spigel, Ishmael A. Jaiyesimi
Publikováno v:
Journal of Clinical Oncology. 41:e10-e20
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically r
Publikováno v:
JCO Oncology Practice. 18:699-702
Autor:
Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew G. Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael A. Jaiyesimi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(28)
Living guidelines are routinely updated guidelines that are developed for selected topic areas with rapidly evolving evidence that drives frequent change in clinical practice. These guidelines are updated on a regular schedule, based on the work of a
Publikováno v:
Journal of Blood Medicine
Heparin-induced thrombocytopenia (HIT) is a recognized clinical entity in patients receiving unfractionated heparin and low–molecular weight heparin. Currently, diagnosing HIT includes the combination of a physician’s clinical suspicion based on
Autor:
Ishmael A. Jaiyesimi
Publikováno v:
Annals of Internal Medicine. 118:749